Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: BMJ Open, BMJ, Vol. 9, No. 7 ( 2019-07), p. e028200-
    Abstract: This study aimed to evaluate the impacts of various forms of religious involvement, beyond individual socioeconomic status, lifestyle factors, emotional well-being and social support, on all-cause and cause-specific mortality in socioeconomic disadvantaged neighbourhoods. Design This is a prospective cohort study conducted from 2002 through 2015. Settings This study included underserved populations in the Southeastern USA. Participants A total of nearly 85 000 participants, primarily low-income American adults, were enrolled. Eligible participants were aged 40–79 years at enrolment, spoke English and were not under treatment for cancer within the prior year. Results We found that those who attended religious service attendance 〉 1/week had 8% reduction in all-cause death and 15% reduction in cancer death relative to those who never attended. This association was substantially attenuated by depression score, social support, and socioeconomic and lifestyle covariates, and further attenuated by other forms of religious involvement. This association with all-cause mortality was found being stronger among those with higher socioeconomic status or healthier lifestyle behaviours. Conclusion Our results indicate that the association between religious services attendance 〉 1/week and lower mortality was moderate but robust, and could be attenuated and modified by socioeconomic or lifestyle factors in this large prospective cohort study of underserved populations in the Southeastern USA.
    Type of Medium: Online Resource
    ISSN: 2044-6055 , 2044-6055
    Language: English
    Publisher: BMJ
    Publication Date: 2019
    detail.hit.zdb_id: 2599832-8
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2017
    In:  Cancer Research Vol. 77, No. 3_Supplement ( 2017-02-01), p. B34-B34
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 77, No. 3_Supplement ( 2017-02-01), p. B34-B34
    Abstract: Purpose: Animal and cell line studies provide biologic plausibility that circulating vitamin D may reduce colorectal cancer risk. However, studies in humans have been inconclusive, and few have considered the role of vitamin D binding protein and free vitamin D. We comprehensively evaluated whether vitamin D biomarkers predict risk of colorectal cancer by measuring circulating level of vitamin D binding protein, and total and free 25-hydroxyvitamin D in pre-diagnostic blood serum samples. We used data from a nested case-control study that includes a large number of African Americans, who typically have lower levels of total vitamin D than those of European descent, and who have been understudied in previous investigations. Methods: Participants of the nested case-control study were drawn from the Southern Community Cohort Study, a prospective cohort study primarily comprised of low-income white and African Americans. Participants aged 40-79 were enrolled into the study from 2002 to 2009, and provided information on lifestyle factors and demographics. Cases were participants who were diagnosed with an incident colorectal cancer after study enrollment and donated a blood sample for the study. Controls were selected through incidence density sampling of the cohort members who had donated a blood sample and were free of any cancer except skin cancer at the time of the case's diagnosis. Controls were individually matched to cases by age at diagnosis, sex, and race at a ratio of two controls for each case. A total of 298 cases and 580 controls were included in the current study. Logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for the associations between vitamin D biomarker levels and colorectal cancer risk. Results: ORs for the associations between total and free 25-hydroxyvitamin D with colorectal cancer risk indicated inverse associations, although all confidence intervals crossed unity. More apparent associations were observed among cases with greater than three years between blood draw and diagnosis. Among these subjects, the adjusted ORs for the comparison between participants in the highest tertile of free 25-hydroxyvitamin D levels compared to those in the lowest tertile were 0.65 (95%CI: 0.38,1.11) for all subjects and 0.46 (95%CI: 0.25,0.84) for African Americans. In participants with greater than three years between blood draw and diagnosis, the inverse association pattern was seen in all strata defined by sex, body mass index, and anatomic site, although not all analyses reached significance at P ≤ 0.05. Small samples size in analyses restricted to whites resulted in unstable estimates. Vitamin D binding protein was not associated with colorectal cancer risk. Conclusions: In our study, total and free 25-hydroxyvitamin D are inversely associated with colorectal cancer risk, particularly in African Americans, suggesting a potential role of vitamin D in colorectal cancer prevention. Citation Format: Shaneda Warren Andersen, Xiao-Ou Shu, Qiuyin Cai, Mark Steinwandel, William J. Blot, Wei Zheng. Total and free vitamin D, vitamin D binding protein, and colorectal cancer risk in the Southern Community Cohort Study. [abstract]. In: Proceedings of the AACR Special Conference on Colorectal Cancer: From Initiation to Outcomes; 2016 Sep 17-20; Tampa, FL. Philadelphia (PA): AACR; Cancer Res 2017;77(3 Suppl):Abstract nr B34.
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2017
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 82, No. 12_Supplement ( 2022-06-15), p. 725-725
    Abstract: Introduction: Epidemiologic studies and controlled trials provide evidence that higher 25-hydroxyvitaminD is associated with improved survival in colorectal cancer (CRC), although there are limited data in African Americans (AAs), who are at greater risk for CRC mortality and vitamin D deficiency. Herein, we report associations between vitamin D serum biomarkers collected at cohort entry up to 15 years prior to CRC onset and CRC tumor subtypes defined by high expression of tumor markers (Ki67, p53, and COX2) that represent cellular processes (proliferation, apoptosis, and inflammation) affected by vitamin D. Importantly, higher expression of these markers reflects greater risk for metastasis and CRC-specific mortality. Methods: Data arise from the Southern Community Cohort Study, a cohort from the southeastern United States where the majority of participants are AA. Incident CRC cases with tumor sample were analyzed (n=104). Expression of cellular Ki67, p53, and COX2 (% positivity) were measured and categorized by literature-defined high vs. low cut-points (20%, 10%, and 20%, respectively). Logistic models adjusted for age, race, and sex were used to measure associations between vitamin D biomarkers: 25-hydroxyvitaminD, vitamin D binding protein (VDBP), and calculated free 25-hydroxyvitaminD (vitamin D not bound by VDBP) and the odds of a more aggressive tumor subtype, defined by higher cellular expression. Associations were assessed in the full sample and the subsample of AAs (n=70). Results: There were 52 tumors with high Ki67 expression, 37 with high p53, and 50 with high COX2. Fifteen tumors had high expression of all three markers. Cases were 55.8±0.4 (mean±SE) years at enrollment (range 40-79). The median 25-hydroxyvitaminD was lower in cases with high p53 expressing tumors compared to low expression (13.5 vs. 18.0 ng/mL, respectively, p = .03). Median values for other biomarkers were similar by tumor subtype (p & gt .05). 25-hydroxyvitaminD was not associated with having a tumor with high Ki67 expression (odds ratio (OR) per 1 SD increase [95% CI] = 1.29 [0.85-1.95] , p-trend = .23), high p53 expression (0.80 [0.52-1.23], p-trend = .30), or high COX2 expression (1.29 [0.83-2.00] , p = .25). We observed null associations for VDBP, and free 25-hydroxyvitaminD with all tumor subtypes. Results were similar in AAs, although higher VDBP was associated with lower odds of high Ki67 tumors (0.45 [0.21-0.97], p-trend = .04 per 1 SD increase). Conclusion: In this sample of predominantly AA CRC cases, we observed no association between vitamin D biomarkers in stored serum and subsequent more aggressive CRC molecular subtypes. More work is needed to characterize the relationship between vitamin D and expression of CRC tumor markers, which may help clarify the protective role of maintaining adequate vitamin D levels in association with CRC. Citation Format: Thomas Lawler, Timothy Su, Qiuyin Cai, Mark Steinwandel, Wei Zheng, William J. Blot, Shaneda Warren Andersen. Biomarkers of circulating vitamin D status and expression of tumor molecular markers Ki67, p53, and COX2 among colorectal cancer cases in the Southern Community Cohort Study [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 725.
    Type of Medium: Online Resource
    ISSN: 1538-7445
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2022
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2022
    In:  Cancer Research Vol. 82, No. 23_Supplement_1 ( 2022-12-01), p. A006-A006
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 82, No. 23_Supplement_1 ( 2022-12-01), p. A006-A006
    Abstract: Background: Obesity may increase colorectal cancer (CRC) risk, primarily through mechanisms of increased inflammation. BMI is the most commonly used measure of adiposity; however, it may less accurately measure adiposity in Black populations, highlighting the need for biomarkers of inflammation to evaluate risk. Herein, we investigate the associations between BMI, albumin as a biomarker of inflammation, and CRC risk. Methods: Participant data arise from 71,141 participants of the Southern Community Cohort Study, of which 724 were diagnosed with incident CRC; 69% of the cohort are Black, and 56% have household income & lt;$15,000. A subset of 277 cases and 642 controls had serum albumin concentration measured from blood samples taken at enrollment. Controls were selected through incidence density sampling of the cohort and individually matched to cases by age, sex, and race. Cox proportional hazards were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for associations between BMI and CRC risk. Conditional logistic regression was used to calculate odds ratios (ORs) and 95%CIs for associations between albumin concentrations and CRC risk. WHO categories of BMI and albumin concentration tertiles determined through the control’s distribution were used. Results: Participants with underweight ( & lt;18.5) compared to normal (18.5-24.9) BMI had increased CRC risk (HR:1.69, 95%CI:0.95-2.98). Null associations were observed between overweight and obese BMI and CRC risk compared to normal BMI participants. Associations between BMI and CRC risk did not vary by sex or race (p-interactions & gt;0.05). Albumin concentration was lower in Black participants and inversely associated with CRC risk (per-standard-deviation increase: OR:0.86, 95%CI:0.74,0.99). Associations were most apparent in participants who self-identified as Black race (OR 0.81, 95%CI:0.68,0.97), or female (OR:0.80, 95%CI:0.65,0.98). There was no evidence that albumin mediated the association between BMI and CRC risk, however BMI modified the association between albumin and CRC (BMI & lt;30: OR: 0.90 95%CI:0.73,1.11; BMI ≥30: OR:0.75, 95%CI:0.60,0.95; p-interaction=0.07). Conclusions: Our results support the role of an inflammatory mechanism to increase CRC risk. The null associations between overweight and obese BMI with CRC risk displays the limited predictive utility of BMI in Black populations. Lower albumin concentrations and increased inflammation in Black populations, particularly in the presence of increased adiposity, may represent a contributing factor to racial disparity in CRC incidence. Citation Format: Shaneda Warren Andersen, Zoe Walts, Ronni Brent, Lisa Parlato. Associations of BMI and albumin with colorectal cancer risk: A prospective cohort study [abstract]. In: Proceedings of the AACR Special Conference on Colorectal Cancer; 2022 Oct 1-4; Portland, OR. Philadelphia (PA): AACR; Cancer Res 2022;82(23 Suppl_1):Abstract nr A006.
    Type of Medium: Online Resource
    ISSN: 1538-7445
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2022
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2017
    In:  Cancer Epidemiology, Biomarkers & Prevention Vol. 26, No. 8 ( 2017-08-01), p. 1242-1247
    In: Cancer Epidemiology, Biomarkers & Prevention, American Association for Cancer Research (AACR), Vol. 26, No. 8 ( 2017-08-01), p. 1242-1247
    Abstract: Background: Previous studies rarely evaluated the associations between vitamin D–binding protein and free vitamin D with colorectal cancer risk. We assessed these biomarkers and total 25-hydroxyvitamin D in relation to colorectal cancer risk in a sample of African Americans. Methods: Cases comprised 224 African American participants of the Southern Community Cohort Study diagnosed with incident colorectal cancer. Controls (N = 440) were selected through incidence density sampling and matched to cases on age, sex, and race. Conditional logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (CI) for associations between biomarker levels and colorectal cancer risk. Results: Vitamin D was inversely associated with colorectal cancer risk where the OR per-SD increase in total and free 25-hydroxyvitamin D were 0.82 (95% CI, 0.66–1.02) and 0.82 (95% CI, 0.66–1.01), respectively. Associations were most apparent among cases diagnosed & gt;3 years after blood draw: ORs for the highest tertile versus the lowest were 0.69 (95% CI, 0.21–0.93) for total 25-hydroxyvitamin D and 0.71 (95% CI, 0.53–0.97) for free 25-hydroxyvitamin D. Inverse associations were seen in strata defined by sex, BMI, and anatomic site, although not all findings were statistically significant. Vitamin D–binding protein was not associated with colorectal cancer risk. Conclusions: Our findings suggest that total and free 25-hydroxyvitamin D may be inversely associated with colorectal cancer risk among African Americans. Impact: These findings highlight a potential role for vitamin D in colorectal cancer prevention in African Americans. Cancer Epidemiol Biomarkers Prev; 26(8); 1242–7. ©2017 AACR.
    Type of Medium: Online Resource
    ISSN: 1055-9965 , 1538-7755
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2017
    detail.hit.zdb_id: 2036781-8
    detail.hit.zdb_id: 1153420-5
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 83, No. 7_Supplement ( 2023-04-04), p. 1909-1909
    Abstract: Purpose: Evidence from RCTs suggests vitamin D supplementation may improve colorectal cancer (CRC) outcomes after diagnosis. However, most trials did not include large numbers of Black patients, who typically have lower vitamin D levels. We evaluated associations between vitamin D with all-cause and CRC-specific mortality after CRC diagnosis. Methods: Data arose from 220 participants of the Southern Community Cohort Study diagnosed with incident CRC. Eligible patients were ages 40-79 at enrollment, non-Hispanic Black, English-speaking, and provided a blood sample at enrollment for biomarker measurement. Patients provided information on lifestyle factors, demographics, and personal medical history, primarily via in-person interviews. Concentration of 25-hydroxyvitamin D was measured from blood samples taken at enrollment and were categorized by the Institute of Medicine’s categories of deficient ( & lt;12ng/mL), inadequate (12-19.9ng/mL), or adequate (≥20ng/mL). Vital status was obtained through linkages with the National Death Index through December 31, 2020. Cox proportional hazards were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for associations between 25-hydroxyvitamin D concentration and mortality. Statistical models adjusted for the following covariates: age at diagnosis, race, sex, cancer stage, education, income, alcohol intake, smoking history, screening history, obesity, insurance coverage, and physical activity. Results: Circulating 25-hydroxyvitamin D concentration was inversely associated with CRC-specific and all-cause mortality. Specifically, patients with pre-diagnosis 25-hydroxyvitamin D concentration categorized as adequate had reduced all-cause mortality in comparison to participants with deficient vitamin D concentration with a HR of 0.58 (95%CI: 0.35, 0.97). Stronger associations between 25-hydroxyvitamin D concentration and all-cause mortality were observed among participants where blood draw occurred three-five years before diagnosis. Associations were strongest among current smokers where the HR for each per-standard deviation increase of 25-hydroxyvitamin D concentration with all-cause mortality was 0.58 (95%CI: 0.36,0.92), and among obese participants the HR for a per-standard deviation increase of 25-hydroxyvitamin D with all-cause mortality was 0.45 (95%CI: 0.27,0.75). An inverse association was also observed with CRC-specific mortality, although the association was attenuated (HR for per-standard deviation increase of 25-hydroxyvitamin D=0.83; 95%CI: 0.63,1.08). Conclusions: Our findings suggest that pre-diagnosis vitamin D concentration is inversely associated with mortality after a CRC diagnosis among Black individuals. Correcting vitamin D deficiency may be warranted among Black CRC patients, particularly for those who smoke or are obese. Citation Format: Shaneda Warren Andersen, Thomas Lawler, Nikhil K. Khankari, Xiao-Ou Shu, Mark D. Steinwandel, Qiuyin Cai, Peter W. Peter W Jurutka, Wei Zheng. Pre-diagnostic vitamin D in association with colorectal cancer- and all-cause mortality: a prospective study among a non-Hispanic Black cohort [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 1909.
    Type of Medium: Online Resource
    ISSN: 1538-7445
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2023
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 7
    In: Menopause, Ovid Technologies (Wolters Kluwer Health), Vol. 20, No. 3 ( 2013-03), p. 354-358
    Type of Medium: Online Resource
    ISSN: 1072-3714
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2013
    detail.hit.zdb_id: 2071114-1
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 8
    In: Cancer Causes & Control, Springer Science and Business Media LLC, Vol. 30, No. 5 ( 2019-5), p. 425-433
    Type of Medium: Online Resource
    ISSN: 0957-5243 , 1573-7225
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2019
    detail.hit.zdb_id: 1496544-6
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 9
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2020
    In:  Cancer Epidemiology, Biomarkers & Prevention Vol. 29, No. 12_Supplement ( 2020-12-01), p. PO-223-PO-223
    In: Cancer Epidemiology, Biomarkers & Prevention, American Association for Cancer Research (AACR), Vol. 29, No. 12_Supplement ( 2020-12-01), p. PO-223-PO-223
    Abstract: Background. Colorectal cancer (CRC) incidence rates have increased in younger individuals worldwide. A recent US study reported increases among both non- Hispanic whites (NHW) and non-Hispanic blacks (NHB), but did not consider other racial/ethnic groups. Thus, we examined the most recent CRC rates for the US by age, race/ethnicity, and anatomic location. Methods. Age-standardized incidence rates (ASR, per 100,000) of CRC were calculated for 2001-2002 through 2015-2016 using the US Cancer Statistics Database, which includes data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program. US Cancer Statistics covers the entire US population. Results were cross- classified by age (20-49 [early-onset] and 50-74 years [late-onset] ), race/ethnicity (NHW, NHB, Hispanic, American Indian/Alaskan Native [AIAN], Asian/Pacific Islander [API] ), and location (proximal, distal, rectal). To examine the change in ASR over time, annual percent change (APC) was calculated using joinpoint regression models. Results. Historically, NHB have had the highest rates of early-onset CRC. However, in 2015-2016, early-onset CRC rates were highest in AIAN (ASR=14.72), followed by NHB (ASR=13.20) and NHW (ASR=12.31). The rate of early-onset proximal colon cancer was highest in NHB (ASR=4.83), which was 62% higher than the rate in NHW (ASR=2.98). Early-onset distal colon and rectal cancer rates were highest in AIAN (ASR=3.98 and 6.43, respectively). Between 2001-2002 and 2015-2016, early-onset CRC rates significantly increased among NHWs (APC=1.62%) and AIAN (APC=3.33%). Racial disparities in incidence of early-onset CRC have decreased between NHB and NHW, due to increasing rates in NHW. Among NHW, early-onset CRC has significantly increased for all CRC locations, with the largest increase for rectal cancer (APC=2.22%). Early-onset rates of rectal cancer also significantly increased for AIAN (APC=4.38%) and Hispanics (APC=0.76%), while rates of proximal colon cancer significantly increased for AIAN (APC=2.21%). Rates of late-onset CRC have significantly decreased in all racial/ethnic groups. However, compared to NHW (ASR=82.48), late-onset CRC rates remain 32% higher in NHB (ASR=108.91) and 18% higher in AIAN (ASR=97.06). Conclusion. Early-onset CRC rates have been increasing, while late-onset CRC rates have decreased. The racial disparity between NHB and NHW in incidence of early-onset CRC has decreased, but this is due to increases in NHW—not decreases in NHB. NHB and AIAN have the highest rates of both early-and late-onset CRC. To counter these trends, research should focus on identifying predictors of early-onset CRC to determine who should be screened prior to age 50 and identify underlying causes of early-onset CRC. Further, ongoing prevention efforts must ensure access to screening colonoscopies for AIAN and NHB. Citation Format: Jessica L. Petrick, Lauren E. Barber, Shaneda Warren Andersen, Andrea A. Florio, Julie R. Palmer, Lynn Rosenberg. Racial disparities in early- and late-onset colorectal cancer incidence, 2001- 2016 [abstract]. In: Proceedings of the AACR Virtual Conference: Thirteenth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2020 Oct 2-4. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2020;29(12 Suppl):Abstract nr PO-223.
    Type of Medium: Online Resource
    ISSN: 1055-9965 , 1538-7755
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2020
    detail.hit.zdb_id: 2036781-8
    detail.hit.zdb_id: 1153420-5
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 10
    In: Supportive Care in Cancer, Springer Science and Business Media LLC, Vol. 32, No. 4 ( 2024-04)
    Type of Medium: Online Resource
    ISSN: 0941-4355 , 1433-7339
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2024
    detail.hit.zdb_id: 1463166-0
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages